CELLFUSE Trademark

Trademark Overview


On Monday, December 31, 2018, a trademark application was filed for CELLFUSE with the United States Patent and Trademark Office. The USPTO has given the CELLFUSE trademark a serial number of 88245691. The federal status of this trademark filing is REGISTERED as of Tuesday, August 4, 2020. This trademark is owned by Regenacell Therapy, Inc.. The CELLFUSE trademark is filed in the Medical Instrument Products category with the following description:

Medical devices, namely, devices to aspirate bone marrow and harvest autologous bone dowels; synthetic bone graft substitute materials; medical apparatus for the delivery of the combination of bone marrow, autologous bone dowels and bone graft material to the surgical site; medical device pack consisting of a combination of medical devices and materials, namely, devices to aspirate bone marrow and harvest autologous bone dowels, synthetic bone graft substitute materials, and medical apparatus for the delivery of the combination of bone marrow, autologous bone dowels and bone graft material to the surgical site
cellfuse

General Information


Serial Number88245691
Word MarkCELLFUSE
Filing DateMonday, December 31, 2018
Status700 - REGISTERED
Status DateTuesday, August 4, 2020
Registration Number6120774
Registration DateTuesday, August 4, 2020
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Pseudo MarkCELL FUSE
Goods and ServicesMedical devices, namely, devices to aspirate bone marrow and harvest autologous bone dowels; synthetic bone graft substitute materials; medical apparatus for the delivery of the combination of bone marrow, autologous bone dowels and bone graft material to the surgical site; medical device pack consisting of a combination of medical devices and materials, namely, devices to aspirate bone marrow and harvest autologous bone dowels, synthetic bone graft substitute materials, and medical apparatus for the delivery of the combination of bone marrow, autologous bone dowels and bone graft material to the surgical site

Classification Information


International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateTuesday, January 22, 2019
Primary Code010
First Use Anywhere DateThursday, August 1, 2019
First Use In Commerce DateTuesday, October 1, 2019

Trademark Owner History


Party NameSTEM GENIX SOLUTIONS LLC
Party Type31 - New Owner After Registration
Legal Entity Type16 - Limited Liability Company
AddressCENTER VALLEY, PA 18034

Party NameRegenacell Therapy, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCastle Rock, CO 80104

Party NameRegenacell Therapy, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCastle Rock, CO 80104

Trademark Events


Event DateEvent Description
Wednesday, March 20, 2024AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, August 4, 2020REGISTERED-SUPPLEMENTAL REGISTER
Wednesday, July 1, 2020LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, June 25, 2020NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
Wednesday, June 24, 2020APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Wednesday, June 24, 2020USE AMENDMENT ACCEPTED
Wednesday, June 3, 2020AMENDMENT TO USE PROCESSING COMPLETE
Friday, March 6, 2020USE AMENDMENT FILED
Tuesday, March 17, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, March 17, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, March 16, 2020ASSIGNED TO LIE
Monday, March 9, 2020TEAS REQUEST FOR RECONSIDERATION RECEIVED
Friday, March 6, 2020TEAS AMENDMENT OF USE RECEIVED
Wednesday, September 11, 2019NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, September 11, 2019FINAL REFUSAL E-MAILED
Wednesday, September 11, 2019FINAL REFUSAL WRITTEN
Tuesday, August 20, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, August 19, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, August 19, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, April 25, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, April 25, 2019NON-FINAL ACTION E-MAILED
Thursday, April 25, 2019NON-FINAL ACTION WRITTEN
Wednesday, March 20, 2019ASSIGNED TO EXAMINER
Tuesday, January 22, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, January 3, 2019NEW APPLICATION ENTERED